MedPath

Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement

Phase 4
Conditions
Coronary Artery Disease
Myocardial Ischemia
Interventions
Other: Maximal Hyperemia with Adenosine Followed by Nicorandil
Other: Maximal Hyperemia with Nicorandil Followed by Adenosine
Registration Number
NCT01331902
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study is to evaluate the efficacy of nicorandil in the achievement of maximal coronary hyperemia compared with adenosine.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • non -infarct related, patients with moderate coronary artery stenosis
  • normal left ventricular ejection fraction on echocardiogram
Exclusion Criteria
  • infarct-related arteries or clinically unstable state
  • collateral blood flow to the target vessel is shown
  • atrioventricular block on electrocardiogram
  • reduced left ventricular ejection fraction (<50%) or left ventricular hypertrophy on echocardiogram
  • contraindication of adenosine
  • bronchial asthma

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Adenosine Followed by NicorandilMaximal Hyperemia with Adenosine Followed by Nicorandil-
Nicorandil Followed by AdenosineMaximal Hyperemia with Nicorandil Followed by Adenosine-
Primary Outcome Measures
NameTimeMethod
Fractional Flow Reserve at Maximal Hyperemia1 day
Secondary Outcome Measures
NameTimeMethod
Time to Maximal Hyperemia1 day
Changes in Heart Rate1 day

Trial Locations

Locations (1)

Cardiovascular Center, Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath